CD96 and melanoma: To investigate if the CD226/CD96-CD155/CD112 tumour cell recognition system is functional in the context of our ovarian and melanoma tumour cells we blocked each component with commercial mAb and performed NK cell functional assays (Fig 4 and S4 Fig).